BioCentury
ARTICLE | Company News

Boehringer submits Spiriva NDA

December 18, 2001 8:00 AM UTC

Boehringer Ingelheim (Ingelheim, Germany) submitted an NDA to the FDA for its Spiriva once-daily inhaled bronchodilator M3 receptor antagonist to treat chronic obstructive pulmonary disease (COPD). Pf...